Cargando…
Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events
Background: Anti-tumor immunotherapy with immune checkpoint inhibitors induces several immune-related adverse events. Camrelizumab-related isolate abducens neuritis is rare. Case presentation: We report on a 67-year-old man with esophageal cancer who presented with acute-onset isolated right abducen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496756/ https://www.ncbi.nlm.nih.gov/pubmed/36138977 http://dx.doi.org/10.3390/brainsci12091242 |
_version_ | 1784794347706777600 |
---|---|
author | Hou, Yanli Su, Qiang Tang, Simeng Li, Hongyang |
author_facet | Hou, Yanli Su, Qiang Tang, Simeng Li, Hongyang |
author_sort | Hou, Yanli |
collection | PubMed |
description | Background: Anti-tumor immunotherapy with immune checkpoint inhibitors induces several immune-related adverse events. Camrelizumab-related isolate abducens neuritis is rare. Case presentation: We report on a 67-year-old man with esophageal cancer who presented with acute-onset isolated right abducens cranial nerve palsy after ten cycles of Camrelizumab treatment. Magnetic resonance imaging examination revealed thickening and post-contrast enhancement at the cisternal segment of the right abducens nerve. The diagnosis was immune-related abducens neuritis caused by Camrelizumab. We put him on oral taper corticoids (methylprednisone) for neuritis treatment without Camrelizumab suspension. One month after treatment, he recovered completely. At the last follow-up, one year after the onset of diplopia, the patient was in good condition without neurological symptom recurrence. Conclusion: Abducens neuritis is a rare immune-related adverse outcome of Camrelizumab. The present case proves the efficacy and safety of using corticoids in the treatment of abducens neuritis. |
format | Online Article Text |
id | pubmed-9496756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94967562022-09-23 Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events Hou, Yanli Su, Qiang Tang, Simeng Li, Hongyang Brain Sci Case Report Background: Anti-tumor immunotherapy with immune checkpoint inhibitors induces several immune-related adverse events. Camrelizumab-related isolate abducens neuritis is rare. Case presentation: We report on a 67-year-old man with esophageal cancer who presented with acute-onset isolated right abducens cranial nerve palsy after ten cycles of Camrelizumab treatment. Magnetic resonance imaging examination revealed thickening and post-contrast enhancement at the cisternal segment of the right abducens nerve. The diagnosis was immune-related abducens neuritis caused by Camrelizumab. We put him on oral taper corticoids (methylprednisone) for neuritis treatment without Camrelizumab suspension. One month after treatment, he recovered completely. At the last follow-up, one year after the onset of diplopia, the patient was in good condition without neurological symptom recurrence. Conclusion: Abducens neuritis is a rare immune-related adverse outcome of Camrelizumab. The present case proves the efficacy and safety of using corticoids in the treatment of abducens neuritis. MDPI 2022-09-14 /pmc/articles/PMC9496756/ /pubmed/36138977 http://dx.doi.org/10.3390/brainsci12091242 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Hou, Yanli Su, Qiang Tang, Simeng Li, Hongyang Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events |
title | Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events |
title_full | Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events |
title_fullStr | Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events |
title_full_unstemmed | Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events |
title_short | Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events |
title_sort | camrelizumab-induced isolate abducens neuritis: a rare ophthalmic immune-related adverse events |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496756/ https://www.ncbi.nlm.nih.gov/pubmed/36138977 http://dx.doi.org/10.3390/brainsci12091242 |
work_keys_str_mv | AT houyanli camrelizumabinducedisolateabducensneuritisarareophthalmicimmunerelatedadverseevents AT suqiang camrelizumabinducedisolateabducensneuritisarareophthalmicimmunerelatedadverseevents AT tangsimeng camrelizumabinducedisolateabducensneuritisarareophthalmicimmunerelatedadverseevents AT lihongyang camrelizumabinducedisolateabducensneuritisarareophthalmicimmunerelatedadverseevents |